全文获取类型
收费全文 | 194篇 |
免费 | 11篇 |
专业分类
儿科学 | 1篇 |
妇产科学 | 10篇 |
基础医学 | 18篇 |
口腔科学 | 2篇 |
临床医学 | 12篇 |
内科学 | 46篇 |
皮肤病学 | 13篇 |
神经病学 | 24篇 |
特种医学 | 2篇 |
外科学 | 27篇 |
预防医学 | 11篇 |
眼科学 | 2篇 |
药学 | 26篇 |
肿瘤学 | 11篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 18篇 |
2020年 | 8篇 |
2019年 | 9篇 |
2018年 | 11篇 |
2017年 | 5篇 |
2016年 | 9篇 |
2015年 | 5篇 |
2014年 | 8篇 |
2013年 | 5篇 |
2012年 | 17篇 |
2011年 | 17篇 |
2010年 | 12篇 |
2009年 | 9篇 |
2008年 | 11篇 |
2007年 | 16篇 |
2006年 | 3篇 |
2005年 | 5篇 |
2004年 | 2篇 |
2003年 | 3篇 |
2002年 | 7篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1998年 | 1篇 |
1992年 | 1篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有205条查询结果,搜索用时 15 毫秒
21.
Elena Llorente Belén Prieto Leyre Cardo Noelia Avello Francisco V Alvarez 《Clinical chemistry and laboratory medicine》2007,45(11):1531-1535
BACKGROUND: Neonatal infection remains a major diagnostic problem because of non-specific clinical signs and symptoms, as well as low sensitivity and specificity of routine laboratory tests. C-reactive protein (CRP), white blood cell count, absolute neutrophil count and immature/total neutrophil ratio are the most widely used tests in the diagnosis of sepsis and provide useful information, but none of these has demonstrated to be reliable in detecting all septic infants. Procalcitonin (PCT) has been suggested as a potentially useful laboratory test performed in umbilical cord blood when perinatal bacterial sepsis is under investigation. METHODS: In this study, the reference interval for umbilical cord blood serum PCT was established for the first time by Time-Resolved Amplified Cryptate Emission (TRACE) technology. RESULTS: The reference interval for PCT in umbilical cord blood serum ranged from 0.04 to 0.43 microg/L in 168 non-infected newborn infants (95% CI 0.02-0.06 and 0.35-0.60 microg/L, respectively). Cord blood serum PCT correctly classified one infected patient out of 90 newborn infants at risk of vertically transmitted sepsis and identified another neonate as a potentially infected patient despite having negative blood cultures. However, cord blood CRP misclassified 21 out of the 90 patients as infected neonates. CONCLUSIONS: Cord blood PCT measured by TRACE is a potentially more useful early marker of neonatal sepsis than cord blood CRP. 相似文献
22.
23.
24.
de Oliveira Sillero R Zanini MA Gabarra RC 《The Journal of trauma》2008,64(6):1619-21; discussion 1621
25.
26.
Leyre Zubiri Rachel P. Rosovsky Meghan J. Mooradian A.J. Piper-Vallillo Justin F. Gainor Ryan J. Sullivan Daniel Marte Genevieve M. Boland Xin Gao Ephraim P. Hochberg David P. Ryan Corey McEwen Minh Mai Tanya Sharova Tara E. Soumerai Aditya Bardia Kerry L. Reynolds 《The oncologist》2021,26(8):e1427-e1433
BackgroundThe coronavirus disease 2019 (COVID‐19) pandemic has significantly impacted health care systems. However, to date, the trend of hospitalizations in the oncology patient population has not been studied, and the frequency of nosocomial spread to patients with cancer is not well understood. The objectives of this study were to evaluate the impact of COVID‐19 on inpatient oncology census and determine the nosocomial rate of COVID‐19 in patients with cancer admitted at a large academic center.Materials and MethodsMedical records of patients with cancer diagnosed with COVID‐19 and admitted were reviewed to evaluate the temporal trends in inpatient oncology census during pre–COVID‐19 (January 2019 to February 2020), COVID‐19 (March to May 2020), and post–COVID‐19 surge (June to August 2020) in the region. In addition, nosocomial infection rates of SARS‐CoV‐2 were reviewed.ResultsOverall, the daily inpatient census was steady in 2019 (median, 103; range, 92–118) and until February 2020 (median, 112; range, 102–114). However, there was a major decline from March to May 2020 (median, 68; range, 57–104), with 45.4% lower admissions during April 2020. As the COVID‐19 surge eased, the daily inpatient census over time returned to the pre–COVID‐19 baseline (median, 103; range, 99–111). One patient (1/231, 0.004%) tested positive for SARS‐CoV‐2 13 days after hospitalization, and it is unclear if it was nosocomial or community spread.ConclusionIn this study, inpatient oncology admissions decreased substantially during the COVID‐19 surge but over time returned to the pre–COVID‐19 baseline. With aggressive infection control measures, the rates of nosocomial transmission were exceedingly low and should provide reassurance to those seeking medical care, including inpatient admissions when medically necessary.Implications for PracticeThe COVID‐19 pandemic has had a major impact on the health care system, and cancer patients are a vulnerable population. This study observes a significant decline in the daily inpatient oncology census from March to May 2020 compared with the same time frame in the previous year and examines the potential reasons for this decline. In addition, nosocomial rates of COVID‐19 were investigated, and rates were found to be very low. These findings suggest that aggressive infection control measures can mitigate the nosocomial infection risk among cancer patients and the inpatient setting is a safe environment, providing reassurance. 相似文献
27.
Isaac A. Klein Shoshana M. Rosenberg Kerry L. Reynolds Leyre Zubiri Rachel Rosovsky Andrew J. Piper-Vallillo Xin Gao Genevieve Boland Aditya Bardia Rachel Gaither Hannah Freeman Gregory J. Kirkner Chanu Rhee Michael Klompas Meghan A. Baker Martha Wadleigh Eric P. Winer Camille N. Kotton Ann H. Partridge 《The oncologist》2021,26(8):685-693
28.
Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia 下载免费PDF全文
Jair Tenorio Ignacio Álvarez Leyre Riancho‐Zarrabeitia Gabriel Á. Martos‐Moreno Giorgia Mandrile Monserrat de la Flor Crespo Mikhail Sukchev Mostafa Sherif Iza Kramer María T. Darnaude‐Ortiz Pedro Arias Gema Gordo Irene Dapía Julián Martinez‐Villanueva Rubén Gómez José Manuel Iturzaeta Ghada Otaify Mayte García‐Unzueta Alessandro Rubinacci José A. Riancho Mona Aglan Samia Temtamy Mohamed Abdel Hamid Jesús Argente Víctor L. Ruiz‐Pérez Karen E. Heath Pablo Lapunzina 《American journal of medical genetics. Part A》2017,173(3):601-610
29.
Leyre Mestre Francisco J. Carrillo-Salinas Ana Feliú Miriam Mecha Graciela Alonso Carmen Espejo 《Gut microbes》2020,12(1)
ABSTRACT A growing number of studies support that the bidirectional interactions between the gut microbiota, the immune system and the CNS are relevant for the pathophysiology of MS. Several studies have reported alterations in the gut microbiome of MS patients. In addition, a variety of studies in animal models of MS have suggested that specific members of the gut commensal microbiota can exacerbate or ameliorate neuroinflammation. Probiotics represent oral nontoxic immunomodulatory agents that would exert benefits when using in combination with current MS therapy. Here we investigate the effect of Vivomixx on the gut microbiome and central and peripheral immune responses in a murine model of primary progressive MS. Vivomixx administration was associated with increased abundance of many taxa such as Bacteroidetes, Actinobacteria, Tenericutes and TM7. This was accompanied by a clear improvement of the motor disability of Theiler’s virus infected mice; in the CNS Vivomixx reduced microgliosis, astrogliosis and leukocyte infiltration. Notably, the presence of Breg cells (CD19+CD5+CD1dhigh) in the CNS was enhanced by Vivomixx, and while spinal cord gene expression of IL-1β and IL-6 was diminished, the probiotic promoted IL-10 gene expression. One of the most significant findings was the increased plasma levels of butyrate and acetate levels in TMEV-mice that received Vivomixx. Peripheral immunological changes were subtle but interestingly, the probiotic restricted IL-17 production by Th17-polarized CD4+ T-cells purified from the mesenteric lymph nodes of Theiler’s virus infected mice. Our data reinforce the beneficial effects of oral probiotics that would be coadjuvant treatments to current MS therapies. 相似文献
30.